Evidence map›Paper›PMID 28257429›Full record

ArticlePloS one2017

Early mutation bursts in colorectal tumors.

Junsong Zhao, Matthew P Salomon, Darryl Shibata, Christina Curtis, Kimberly Siegmund, Paul Marjoram

Abstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Spatial mutation patterns as markers of early colorectal tumor cell mobility.Proceedings of the National Academy of Sciences of the United States of America · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Junsong ZhaoDepartment of Molecular and Computational Biology, University of Southern California, Los Angeles, California, United States of America.ORCID http://orcid.org/0000-0001-5167-1363
Matthew P SalomonDepartment of Molecular Oncology, John Wayne Cancer Institute at Providence Saint John's Health Center, Santa Monica, California, United States of America.
Darryl ShibataDepartment of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.
Christina CurtisDepartment of Medicine (Oncology) and Genetics, School of Medicine, Stanford University, Stanford, California, United States of America.
Kimberly SiegmundDepartment of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, United States of America.
Paul MarjoramDepartment of Molecular and Computational Biology, University of Southern California, Los Angeles, California, United States of America.

Funding

USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORTP30CA014089 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Fumito Ito · 1985 to 2026
$181.4M
Statistical Methods for Integrative Genomics in CancerP01CA196569 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI David V Conti · 2016 to 2026
$25.5M
Statistical Analysis of Epigenomics DataR01HG006705 · NHGRI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI SIEGMUND, KIMBERLY D · 2013 to 2015
$1.1M
"Born to be Bad": Is Abnormal Cell Mobility Already Present At Initiation?R21CA185016 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI SHIBATA, DARRYL K · 2014 to 2015
$394k
Applying Molecular Phylogeny to Predict Clinical Outcomes in CancerR21CA151139 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI SIEGMUND, KIMBERLY D · 2010 to 2011
$383k
NCI NIH HHS P01 CA196569NCI NIH HHS P30 CA014089NCI NIH HHS R21 CA151139NCI NIH HHS R21 CA185016NHGRI NIH HHS R01 HG006705
6 · The paper itself

Abstract

Tumor growth is an evolutionary process involving accumulation of mutations, copy number alterations, and cancer stem cell (CSC) division and differentiation. As direct observation of this process is impossible, inference regarding when mutations occur and how stem cells divide is difficult. However, this ancestral information is encoded within the tumor itself, in the form of intratumoral heterogeneity of the tumor cell genomes. Here we present a framework that allows simulation of these processes and estimation of mutation rates at the various stages of tumor development and CSC division patterns for single-gland sequencing data from colorectal tumors. We parameterize the mutation rate and the CSC division pattern, and successfully retrieve their posterior distributions based on DNA sequence level data. Our approach exploits Approximate Bayesian Computation (ABC), a method that is becoming widely-used for problems of ancestral inference.

Indexed as

Genetic HeterogeneityBayes TheoremCarcinogenesisColorectal NeoplasmsComputer SimulationDNA Copy Number VariationsDNA MethylationHumansMicrosatellite RepeatsMutationNeoplastic Stem Cells

Identifiers

PMID28257429
PMCPMC5336211

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.